Skip to main content
. 2022 Jan 21;45(3):642–649. doi: 10.2337/dc21-2056

Table 1.

Regional variation in referrals for genetic testing for MODY and cases of diabetes with a confirmed diagnosis of MODY from 1 January 1996 to 31 December 2019

Probands
Country/region Population Referrals, n Referrals/ million With mutation, n Positive test rate, % Relatives with diabetes with mutation, n Total cases,* n Total cases/ million
Scotland 5,463,300 1,369 250.6 265 19.4 178 443 81.1
Wales 3,152,879 255 80.9 69 27.1 60 129 40.9
Northern Ireland 1,893,667 127 67.1 23 18.1 23 46 24.3
England 56,286,961 6,781 120.5 1,724 25.4 1,479 3,203 56.9
English regions
 East 6,236,072 571 91.6 154 27.0 145 299 47.9
 South East 9,180,135 1,163 126.7 346 29.8 280 626 68.2
 South West 5,624,696 1,402 249.3 312 22.3 325 637 113.3
 London 8,961,989 1,019 113.7 246 24.1 145 391 43.6
 West Midlands 5,934,037 461 77.7 120 26.0 122 242 40.8
 East Midlands 4,835,928 393 81.3 115 29.3 99 214 44.3
 Yorkshire/Humber 5,502,967 543 98.7 153 28.2 121 274 49.8
 North East 2,669,941 448 167.8 92 20.5 59 151 56.6
 North West 7,341,196 781 106.4 186 23.8 183 369 50.3
 Unknown 5 2 37 39
U.K. total 66,796,807 8,537 127.8 2,083 24.4 1,777 3,860 57.8

Proband referral rates and confirmed cases were calculated per million of regional population.

*

Probands and relatives.

Minimum percent positive test rate based on number of probands with mutations identified per all proband referrals for region specified.